LUPUS
Clinical trials for LUPUS explained in plain language.
Never miss a new study
Get alerted when new LUPUS trials appear
Sign up with your email to follow new studies for LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR cell therapy trial for tough lupus cases withdrawn before starting
Disease control TerminatedThis early-stage study aimed to test the safety and initial effects of a single infusion of CB-010, a new type of cell therapy modified with CRISPR gene-editing, in adults with severe lupus that hasn't responded to standard treatments. The trial was designed to last about two yea…
Matched conditions: LUPUS
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New program aims to bridge healthcare gap for arthritis patients
Disease control OngoingThis study is testing different ways to help people with inflammatory arthritis who face life challenges like unstable housing or transportation issues that make it hard to get medical care. It compares three levels of support: a simple resource list, help from a community specia…
Matched conditions: LUPUS
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC